Business · 15/03/2011Updated: 10/17/2026 · 1 min read
FDA Reopens Comment Period for Generic Drug User Fee Program
Summary
The Food and Drug Administration (FDA) is extending the public comment period for its generic drug user fee program until June 30, 2011, to gather stakeholder input and ensure all interested parties can share their views on the matter.
Original source language: Federal Register — Health and Human ServicesOpen original release →